ProtoKinetix Inc (PKTX)

[saigai]

repost from a yahoo post

PKTX, ProtoKinetix – PKTX has doubled over the last couple of months and I think it may just be getting started. The company just announced a Material Transfer Agreement(MTA) with an unnamed major biotech company. For those of you unfamiliar with an MTA, they are typically a precursor to a licensing agreement. The results of the data will be made known to PKTX by midsummer. This is significant from two aspects. First, the PKTX technology is far enough along to enter into an MTA. The other company would have done a fair amount of due diligence prior to entering into the MTA. This means that PKTX is near commercialization. This is no longer a pure r&d experiment. Secondly, if the results are in line with what the company is looking for, there could be a license agreement in place in 2018. As a reminder, the market has not heard of PKTX. Once a deal with a named company is signed, this will change and PKTX will be my next CSBR. The company is debt free and an extremely low burn rate and to top it all off the CEO has bought millions of shares and has been buying recently. This stock is still underfollowed, which brings with it some days with low volume and some price volatility. I’d be buying this one as long-term investment with the benefit of some short-term news that can potentially pop the stock.